ArticleTranslational oncology2010

Inhibition of the MET Receptor Tyrosine Kinase as a Novel Therapeutic Strategy in Medulloblastoma.

Paul N Kongkham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.